Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC today announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for its Prednisolone Sodium Phosphate Oral Solution (10mg Prednisolone per 5mL & 20mg Prednisolone per 5mL). Edenbridge intends to begin shipping this newly approved product shortly. For more information please contact the Company directly at info@dexcelpharmausa.com.
Prednisolone Sodium Phosphate Oral Solution (10mg per 5mL & 20mg per 5mL) Approval
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.